A carregar...
Disease‐Modifying Treatments for Progressive Supranuclear Palsy
In recent years, research has focused on the development of disease‐modifying treatments for PSP, targeting mainly at tau dysfunction. However, the glycogen synthase kinase 3 inhibitor, tideglusib, and the microtubuli stabilizer, davunetide, both failed to show efficacy in recent double‐blind, place...
Na minha lista:
| Publicado no: | Mov Disord Clin Pract |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6183250/ https://ncbi.nlm.nih.gov/pubmed/30363906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12142 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|